Literature DB >> 17719198

Effect of light and heat on the stability of montelukast in solution and in its solid state.

Mahmoud M Al Omari1, Rufaida M Zoubi, Enas I Hasan, Tariq Z Khader, Adnan A Badwan.   

Abstract

The chemical stability of montelukast (Monte) in solution and in its solid state was studied. A simultaneous measurement of Monte and its degradation products was determined using a selective HPLC method. The HPLC system comprised a reversed phase column (C18) as the stationary phase and a mixture of ammonium acetate buffer of pH 3.5 and methanol (15:85 v/v) as the mobile phase. The UV detection was conducted at 254 nm. Monte in solution showed instability when exposed to light leading to the formation of its cis-isomer as the major photoproduct. The rate of photodegradation of Monte in solution exposed to various light sources increases in the order of; sodium<neon<tungsten<daylight<UV (254 nm). The extent of photodegradation was influenced by solvent type, where Monte was found to be most stable in 70% methanol. In solid state, Monte showed more than 20% decrease in its potency after exposure to daylight for 1 week. Also unpacked Monte chewable tablets, exposed to daylight for 2 weeks, showed a decrease of about 10% with the formation of Monte S-oxide as a major photoproduct. On the other hand, Monte film-coated tablets either unpacked or in its immediate pack showed excellent stability under the same condition. The thermal stress testing study of Monte in solutions at 65 degrees C showed that it is highly stable in NaOH solution, while it degrades rapidly in both acidic and H2O2 solutions. The major degradation product in the latter solvent was Monte S-oxide and it was also detected as a major degradation product in Monte tablet dosage form during the incubation at 40 degrees C/75% RH for 6 months. Findings of this study have helped to understand the stability behavior of Monte and to establish the critical parameters, which may affect its analysis and manufacturing activities.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17719198     DOI: 10.1016/j.jpba.2007.07.014

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  8 in total

1.  Development and Validation of a RP-HPLC Method for Estimation of Montelukast Sodium in Bulk and in Tablet Dosage Form.

Authors:  R M Singh; P K Saini; S C Mathur; G N Singh; B Lal
Journal:  Indian J Pharm Sci       Date:  2010-03       Impact factor: 0.975

2.  Formulation and in vitro and in vivo evaluation of film-coated montelukast sodium tablets using Opadry® yellow 20A82938 on an industrial scale.

Authors:  Abdel Naser Zaid; Salam Natour; Aiman Qaddomi; Abeer Abu Ghoush
Journal:  Drug Des Devel Ther       Date:  2013-02-07       Impact factor: 4.162

3.  Method development and validation of montelukast in human plasma by HPLC coupled with ESI-MS/MS: application to a bioequivalence study.

Authors:  Balasekhara Reddy Challa; Bahlul Z Awen; Babu Rao Chandu; Mukkanti Khagga; Chandrasekhar Bannoth Kotthapalli
Journal:  Sci Pharm       Date:  2010-06-04

4.  Co-processed chitin-mannitol as a new excipient for Oro-dispersible tablets.

Authors:  Nidal Daraghmeh; Babur Z Chowdhry; Stephen A Leharne; Mahmoud M H Al Omari; Adnan A Badwan
Journal:  Mar Drugs       Date:  2015-03-30       Impact factor: 5.118

5.  Development and validation of LC/MS/MS method for the simultaneous determination of montelukast, gliclazide, and nifedipine and its application to a pharmacokinetic study.

Authors:  Essam Ezzeldin; Nisreen F Abo-Talib; Marwa H Tammam; Abdelaaty A Shahat
Journal:  Chem Cent J       Date:  2014-03-11       Impact factor: 4.215

6.  Design, Formulation, and Physicochemical Evaluation of Montelukast Orally Disintegrating Tablet.

Authors:  Abolfazl Aslani; Maryam Beigi
Journal:  Int J Prev Med       Date:  2016-10-26

7.  Structural confirmation of sulconazole sulfoxide as the primary degradation product of sulconazole nitrate.

Authors:  Qun Xu; Ashraf Khan; Di Gao; Kristie M Adams; Fatkhulla Tadjimukhamedov; Shane Tan; John T Simpson
Journal:  J Pharm Anal       Date:  2017-12-19

8.  Montelukast Nanocrystals for Transdermal Delivery with Improved Chemical Stability.

Authors:  Sung Hyun Im; Hoe Taek Jung; Myoung Jin Ho; Jeong Eun Lee; Hyung Tae Kim; Dong Yoon Kim; Hyo Chun Lee; Yong Seok Choi; Myung Joo Kang
Journal:  Pharmaceutics       Date:  2019-12-23       Impact factor: 6.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.